NEW YORK -- The FDA issued a warning to patients about the EpiPen on Tuesday. In a news release, FDA said EpiPen manufacturers Pfizer and Mylan sent a letter to health care providers noting the EpiPen ...

On Friday, the FDA approved ARS Pharmaceuticals Inc’s (NASDAQ:SPRY) neffy (epinephrine nasal spray) for the emergency treatment of allergic reactions (Type I), including those that are ...

SOUTH BEND, IN (WSBT) — The FDA has approved the first ever nasal medication called “Neffy” for severe allergies. It’s a new alternative to the well-known EpiPen. Severe allergic reactions are scary, ...

TYLER, Texas (KLTV) - In early August, the FDA announced the approval of a nasal spray epinephrine alternative known as Neffy, which is expected to be in pharmacies and doctor’s offices by the first ...

My son Thomas has carried around a needle since he entered kindergarten at the age of 5. That was a big responsibility for a small child to carry an injector loaded with lifesaving epinephrine, but ...

Please provide your email address to receive an email when new articles are posted on . Epinephrine may be given via intramuscular and subcutaneous injections. Intramuscular and subcutaneous ...

CVS Health, which owns more than 9,600 retail pharmacies and 1,100 walk-in clinics, will offer a lower-cost generic version of the Adrenaclick epinephrine auto-injector, targeting Mylan after the ...

Share on Pinterest In the case of a severe allergic reaction, study results showed that epinephrine delivered via the nose had a similar influence on heart rate and blood pressure as an injection.

LOVELAND, Colo. — The Hiatt Farms Montessori School is now carrying several epinephrine injector doses — or Epipens — thanks to the program "Epipen 4 Schools." Nurse practitioner Lindsay Green, whose ...

In 2021, Governor John Carney signed Senate Bill 55 to expand access to epinephrine auto-injectors — better known by brand name EpiPen — in Delaware colleges and universities. Beginning this fall, the ...

A new docudrama premiering in Kansas City this month puts the spotlight on EpiPen access as Missouri and Kansas City debate ...